Skip to main content
XCUR
NASDAQ Life Sciences

Exicure Seeks Votes to Sell Up to $10M of Stock at Up to a 25% Discount and Double Authorized Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.06
Mkt Cap
$6.677M
52W Low
$0.875
52W High
$9.48
52W Position info
21% above low
Off High info
89% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

XCUR sits 21% above its 52-week low of $0.875.

Summary

Exicure's preliminary proxy asks shareholders to approve up to $10 million of private placements at as little as 75% of the Nasdaq Minimum Price, double authorized shares to 400 million, and adopt a new equity plan reserving 15% of shares outstanding. All of it goes to a vote on December 2, 2026, as the company runs low on cash.


Key Events · Financing and Capital Events · XCUR

  • Up to $10M Private Placement Authorized

    Proposal 3 would let Exicure issue more than 20% of its outstanding stock in private placements over the three months after approval, for maximum aggregate gross proceeds of up to $10,000,000.

  • Units Priced at 25% Discount Floor

    Each unit is one share plus three five-year warrants, priced at the lesser of $1.30 or 75% of the Nasdaq Minimum Price at signing; warrants strike at no less than 110% of the unit price, so shares issued or issuable can reach four times the units sold.

  • Authorized Shares Would Double

    Proposal 5 raises authorized common stock from 200,000,000 to 400,000,000 shares (total authorized capital from 210,000,000 to 410,000,000); no shares are issued by the amendment itself.

  • New Equity Plan Reserves 15% of Shares

    The 2026 Omnibus Incentive Plan reserves 981,899 shares, equal to 15% of the 6,545,995 shares outstanding as of October 27, 2026, with an annual evergreen increase back to 15%.


Analysis · XCUR · Life Sciences

Shareholders are being asked to pre-approve a private placement of up to $10 million, and the terms carry a built-in discount of at least 25% to the market floor: units are priced at the lesser of $1.30 per unit or 75% of the Nasdaq Minimum Price at signing. Each unit carries one share plus three five-year warrants struck at 110% of the unit price, so the share count issued or issuable can reach four times the number of units sold. Against 6,545,995 shares outstanding, the 20%-plus issuance this authorizes is heavily dilutive. At the same time, the company is asking to double authorized common stock to 400 million shares and to reserve 981,899 shares (15% of shares outstanding) for a new equity plan. The backdrop is tight: the Q2 2026 10-Q showed $1.7M of cash, stockholders' equity below Nasdaq's minimum and a going concern warning, with a December 2, 2026 compliance deadline already extended by Nasdaq. The vote is the gate — without it, the company says its financing alternatives would be severely limited.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XCUR was trading at $1.06 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.88 to $9.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Nov 16, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.07
Real-time Price: $1.08 info
Change: +$0.010 (+0.93%) info
Market Cap: $7.07M info
XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.08 info
Change: -$0.0010 (-0.09%) info
Market Cap: $7.07M info
XCUR
Nov 10, 2026, 3:50 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.08 info
Change: -$0.0010 (-0.09%) info
Market Cap: $7.07M info
XCUR
Sep 16, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $1.08 info
Change: -$0.225 (-17%) info
Market Cap: $7.07M info
XCUR
Aug 14, 2026, 3:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $1.08 info
Change: -$0.180 (-14%) info
Market Cap: $7.07M info